NASDAQ: NGEN
Nervgen Pharma Corp Stock Ownership - Who owns Nervgen Pharma?

Insider buying vs selling

Have Nervgen Pharma Corp insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NGEN insiders and whales buy or sell their stock.

NGEN Shareholders

What type of owners hold Nervgen Pharma Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Empery Asset Management LP0.00%3,309$6.02kInstitution
Valley Forge Investment Consultants Inc Adv0.00%834$1.52kInstitution
Marshall Wace LLP0.00%617$1.12kInstitution
Ghisallo Capital Management LLC0.00%500$910.00Institution
Two Sigma Investments LP0.00%463$842.66Institution
Ubs Group Ag0.00%284$516.88Institution
Pfg Investments LLC0.00%242$440.44Institution
Stonepine Capital Management LLC0.00%200$364.00Institution
Bank Of America Corp0.00%162$294.84Institution
Bank Of Montreal0.00%70$127.40Institution

1 of 3

NGEN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NGEN0.01%0.00%
ACIU0.02%4.42%Net Selling
LCTX0.02%60.41%Net BuyingNet Buying
YARW0.03%99.97%Net Selling
CYPH0.02%99.98%Net BuyingNet Buying

Nervgen Pharma Stock Ownership FAQ

Who owns Nervgen Pharma?

Nervgen Pharma (NASDAQ: NGEN) is owned by 0.01% institutional shareholders, 0.00% Nervgen Pharma insiders, and 99.99% retail investors. Empery Asset Management LP is the largest individual Nervgen Pharma shareholder, owning 3309.00 shares representing 0.00% of the company. Empery Asset Management LP's Nervgen Pharma shares are currently valued at $6.49k.

If you're new to stock investing, here's how to buy Nervgen Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.